Resource

EQS-News: EcoGraf Limited: 127% Increase in the Epanko Mineral Resource

Retrieved on: 
Wednesday, March 13, 2024
Prospectors, Metallurgy, TGC, Cell, Data mining, MSP, KfW IPEX-Bank, Resource, KfW, Carbon, SML, ASX, Classification, MRE, DD, PDAC, Graphite, RC, Competent person, Mineral

The Mineral Resource shows a significant increase in tonnes for the Inferred, Indicated and Measured categories of the block model, compared to the previously reported Mineral Resource in 2023.

Key Points: 
  • The Mineral Resource shows a significant increase in tonnes for the Inferred, Indicated and Measured categories of the block model, compared to the previously reported Mineral Resource in 2023.
  • The increase in the Measured volumes result from infill drilling of gaps within the Indicated Resource of the Western Zone.
  • The Mineral Resource infill drilling targeted the Inferred northern and southern parts of the Epanko Western Zone, with a combination of RC and DD drilling.
  • Figure 4 shows a long section through the Epanko West deposit, showing the updated Mineral Resource classification categories applied to the block model.

Tudor Gold Significantly Increases Ounces and Grade in an Updated Mineral Resource Estimate for the Goldstorm Deposit at Treaty Creek, British Columbia with an Indicated Mineral Resource of 27.87 Moz AuEQ at 1.19 g/t AuEQ

Retrieved on: 
Tuesday, February 20, 2024
Inference, Technical report, Copper, Deposit, Ministry, Mining, Project, News, Nisga'a, Resource, PEA, JDS, MRE, National instrument, First Nations, Mineral Resources Limited, AG, Rare-earth element

The 2023 drilling improved our geologic understanding of the mineralization in the northern portion of the deposit.

Key Points: 
  • The 2023 drilling improved our geologic understanding of the mineralization in the northern portion of the deposit.
  • The NS-STK Domain was reinterpreted to be a NE-SW trending stockwork and is associated with the 300H Domain mineralization.
  • We not only pushed out the edges of the Deposit, but we also successfully increased the grade of the Inferred Mineral Resource.
  • Tudor Gold understands and acknowledges that the Nisga'a and Tahltan also assert interests in the Treaty Creek area.

Strong FY 2023 results, Planisware consistently delivering sustainable profitable growth

Retrieved on: 
Monday, March 11, 2024
Corporate social responsibility, PSO, Algorithm, CSRD, Human voice, Core, Intelligence, NRR, UX, ROI, Marketing, IOS, Growth, CSR, Resource, Nature, ESG, SBT, Adjustment, Gartner, Risk, IPO, CDP, Social behavior, Monte, User, Customer, Software as a service, Android, Risk assessment, Public expenditure, Organization, Policy, Heart, DCMA, Annual, Science, Artificial intelligence, Euronext Paris, FTE, DQA, Risk management

At € 6.9 million, 2023 income tax expense reflected an Effective Tax Rate of 14.1%, compared to 15.5% in 2022.

Key Points: 
  • At € 6.9 million, 2023 income tax expense reflected an Effective Tax Rate of 14.1%, compared to 15.5% in 2022.
  • In 2023, adjusted Free Cash Flow reached
    € 43.8 million, up by +64.4% compared to € 26.7 million in 2022, led by Adjusted EBITDA growth.
  • Planisware benefits from a strong cash position, as most of its customers prepay for services, which generates structurally negative working capital requirements.
  • In 2023, Planisware initiated the next phase of its growth strategy through its contemplated IPO on Euronext Paris.

Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting

Retrieved on: 
Friday, March 8, 2024
Janus, Model, Spleen, STAT6, Doctor of Philosophy, Inflammation, Atopic dermatitis, Immunoglobulin E, Resource, JAK, Therapy, Inflammatory bowel disease, Protein, TYK2, TPD, Stem cell, Biology, Serum, Phase 1, American Academy, Pharmaceutical industry

WATERTOWN, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that its preclinical data demonstrating the therapeutic potential of its potent and selective heterobifunctional degraders of STAT6 (KT-621) and TYK2 (KT-294) are being presented in the poster session at the American Academy of Dermatology’s Annual Meeting in San Diego, California. Kymera’s oral STAT6 and TYK2 degraders have the potential to address multiple immune-mediated diseases and overcome the limitations of existing technologies and agents. Today’s poster presentations mark the first time that data from a STAT6 targeted agent and a TYK2 degrader have been shared at a major medical meeting. Based on the results generated to date, Kymera intends to initiate Phase 1 testing for KT-621 and KT-294 in the in the second half of 2024 and the first half of 2025, respectively. Data from both Phase 1 trials are expected to be reported in 2025.

Key Points: 
  • Kymera’s oral STAT6 and TYK2 degraders have the potential to address multiple immune-mediated diseases and overcome the limitations of existing technologies and agents.
  • Today’s poster presentations mark the first time that data from a STAT6 targeted agent and a TYK2 degrader have been shared at a major medical meeting.
  • “Our differentiated strategy to targeted protein degradation has resulted in an industry-leading immunology pipeline of oral degrader medicines, each with the potential to treat multiple complex immuno-inflammatory diseases.
  • At low daily oral doses, preclinical studies with KT-621 demonstrated near full in vivo STAT6 degradation in disease-relevant tissues that was well-tolerated.

NJ Waterproofing Company Praises New Flood Risk Law That Takes Effect March 20

Retrieved on: 
Thursday, March 7, 2024
Criminal defense lawyer, Water damage, Resource, Lease

Beginning March 20, landlords and real property sellers must reveal whether their property is in FEMA’s special flood hazard area or moderate flood hazard area.

Key Points: 
  • Beginning March 20, landlords and real property sellers must reveal whether their property is in FEMA’s special flood hazard area or moderate flood hazard area.
  • According to the waterproofing experts at BSMT Waterproofing in Basking Ridge, the law is long overdue.
  • “We’re very satisfied that the new law was passed,” said Marion Yates, BSMT Waterproofing co-founder.
  • According to Yates, basement waterproofing is an absolute must for mitigating and preventing costly flood damage.

Calibre Continues to Intersect Shallow Open Pit Mineable Grades and Widths at the Volcan Gold Deposit, located Approximately 5 Kilometres From the Libertad Mill; Drilling Intersects Include 15.01 g/t Gold over 2.6 metres and 6.37 g/t Gold over 3.3 metres

Retrieved on: 
Tuesday, March 5, 2024
CXB, ETW, TSX, Labrador, Resource, Vein, Gold, OTCQX, Nightclub

Previous results led to the declaration of an initial open pit Mineral Resource Estimate in September of 2023.

Key Points: 
  • Previous results led to the declaration of an initial open pit Mineral Resource Estimate in September of 2023.
  • These new results support advancing toward a mining decision in mid-2024 with permitting ongoing.
  • Note: Estimated True Widths for reported vein intercepts are based on 3D models of the individual veins.
  • The grinding building is now fully enclosed, and the Company has awarded the structural, mechanical, and piping contract to The Gisborne Group.”

MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market

Retrieved on: 
Tuesday, March 5, 2024
Concierge medicine, OTCQB, AI, Intelligence, Growth, Resource, Mathematical optimization, Patient, Investment, Medical device

VANCOUVER, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that MedMatrix, a product in which it has a significant investment, has announced the go-to-market pricing for both existing beta customers and new customers for its AI product suite.

Key Points: 
  • VANCOUVER, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that MedMatrix, a product in which it has a significant investment, has announced the go-to-market pricing for both existing beta customers and new customers for its AI product suite.
  • Last week, the MedMatrix AI five-feature product suite was announced to sell into the global outpatient clinic market.
  • With the launch of the final commercial product suite and pricing schedule, MedBright’s management is turning its attention to offering MedMatrix’s services to additional clinics.
  • MedMatrix also includes a free trial without any commitment so providers can see the results of the five feature product suite before committing to using the tool.

McEwen Mining: Stock Exploration Update

Retrieved on: 
Wednesday, February 28, 2024
ISO, Mining, Risk, News, TSX, Resource, Stock, Database, Reasonable, Economy, COVID-19, MSO, Security (finance), MacEwen

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to report on three outcomes of its large exploration investment at the Stock Mine property, part of the Fox Complex, in the prolific Timmins gold district of Northern Ontario, Canada: One, a 31% year over year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with Two, confirmation of good grading structures plunging to depth; and Three, Stock East emerging as a potential new near-term source of future revenue.

Key Points: 
  • For this update, an additional 272 drillholes (100,834 m) were added to the database since the last resource update in December 2022.
  • This resource statement does not include the Stock East deposit, which had its own mineral resource estimation updated in March 2022; there is a separate Mineral Resource Statement for Stock East.
  • Exploration drill core samples at the Stock Complex were typically submitted as 1/2 core.
  • The NYSE and TSX have not reviewed and do not accept responsibility for the adequacy or accuracy of the contents of this news release, which has been prepared by management of McEwen Mining Inc.

MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite

Retrieved on: 
Tuesday, February 27, 2024
Concierge medicine, OTCQB, AI, Intelligence, RCM, Resource, Mathematical optimization, Patient, Investment, Medical device

As a result of the beta testing period, management has chosen a five-feature product suite to sell into the global outpatient facility market.

Key Points: 
  • As a result of the beta testing period, management has chosen a five-feature product suite to sell into the global outpatient facility market.
  • Providers can simulate facility moves or expansion of additional clinics to predict the impact on their top and bottom line.
  • As a next step, MedMatrix plans to unveil its revenue generating go-to-market strategy as it transitions current beta customers to commercial agreements.
  • “It is gratifying to complete the beta phase as we move towards the revenue generation phase of the MedMatrix product,” said Trevor Vieweg, CEO of MedBright.

Newcore Gold Announces Addition of Omanpe Prospecting License and Completion of an Updated Environmental and Social Baseline Study at the Enchi Gold Project, Ghana

Retrieved on: 
Tuesday, February 27, 2024
Diamond, Engineering, Technical report, Person, Mining, News, African, Noise, Intertek, Study, Consultant, PEA, Map, Soil, Resource, OTCQX, Water, Ministry, Biophysical environment, Baseline Study, Gold, Knowledge, RC, BBA, Collection, Micon, Climate, Enchi, Nature, Geology, Natural Resources, National instrument, Mineral Resources Limited, Rare-earth element

In addition, Newcore has completed an updated Environmental and Social Baseline Study for the Project (the "2023 Baseline Study" or the "Study"), an important milestone in continuing to de-risk and advance the Project towards production.

Key Points: 
  • In addition, Newcore has completed an updated Environmental and Social Baseline Study for the Project (the "2023 Baseline Study" or the "Study"), an important milestone in continuing to de-risk and advance the Project towards production.
  • Previously completed exploration work at the Omanpe Gold Target ("Omanpe"), including geophysical and geochemical surveys, generated gold-in-soil anomalies, adding several early-stage gold targets to the district-scale potential at Enchi.
  • Completion of an updated environmental and social baseline study continues to de-risk and advance development of the Project.
  • Luke Alexander, President and CEO of Newcore stated, "We are excited to meaningfully increase the size of our Enchi Gold Project.